Data for: A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy

Published: 26 April 2021| Version 1 | DOI: 10.17632/fs9jv7g3v7.1
Contributor:
Geoffrey Stone

Description

Raw data for figures in manuscript

Files

Categories

Immune Response, HIV Vaccine

Licence